Navigation Links
Groups Join Forces to Fund Promising Lung Cancer Research

Two health groups are joining forces to fund three promising lung cancer researchers. The LUNGevity Foundation and the American Cancer Society// are contributing $370,000 to fund the first-ever LUNGevity Foundation and American Cancer Society Lung Cancer Postdoctoral Fellowships. The grants will go to three researchers whose novel approaches may help improve the understanding of how lung cancer develops and could lead to more effective treatments.

The new collaboration will fund three promising research grant applications, grants that passed a rigorous peer review process but could not be funded because of a shortfall of available funds. The three post-doctoral researchers who will receive support are:

?Timothy K. Starr, PhD, University of Minnesota, Twin Cities, whose work on the "Sleeping Beauty transposase” will identify genes specifically involved in lung tumor formation;

?Steven P. Zielske, PhD, University of Michigan, who hopes to modify special cells so they can deliver high concentrations of chemotherapy to lung tumors; and

?Dwight Seferos, PhD, Northwestern University, who will develop a strategy to use nanoparticles to deliver a highly concentrated package of therapies to a specific cellular target.

"It gives us great satisfaction to see these promising researchers get the support they deserve,” said John Stevens, MD, American Cancer Society vice president of extramural grants. "These new fellowships join 76 other multi-year lung cancer research grants totaling more than $42 million the Society currently funds, as we continue to look for answers to improve the lives and prognoses for patients with this top cause of cancer death in the United States.”

"These fellowships are a wonderful opportunity for LUNGevity to continue our support for the most promising lung cancer research,” said Jill Feldman, president of the LUNGevity Foundation. "We are determined to invest in this type of leading-edge research until a cure can be found to treat the 200,000 American diagnosed with lung cancer each year.” Funding for the grants was also provided by a generous estate gift from Catherine and Timothy Fitzgerald to the American Cancer Society.

The American Cancer Society is dedicated to eliminating cancer as a major health problem by saving lives, diminishing suffering and preventing cancer through research, education, advocacy and service. Founded in 1913 and with national headquarters in Atlanta, the Society has 13 regional Divisions and local offices in 3,400 communities, involving millions of volunteers across the United States.

As the pioneer organization dedicated to lung cancer research, LUNGevity Foundation is the leading private provider of research funding for the nation's number one cancer killer. The Foundation's goal is to save the lives of the 200,000 Americans newly diagnosed with lung cancer each year, eighty-five percent of whom will die within five years without the development of new treatment methods. Partnering with the foremost physicians and research scientists in the world, the LUNGevity Foundation funds innovative research designed to treat and cure lung cancer. Source: American Cancer Society
SM/B
'"/>




Related medicine news :

1. Yogic Moments: Age Old Yoga, Benefits All Age Groups
2. Plastic Surgery Is Primetime among Ethnic Groups
3. Study Finds Online Support Groups Emotionally Benefit Women Suffering From
4. Specialist Services Can Help Ethnic Groups To Tackle Alcohol Misuse
5. Distinct Support Services Needed, To Resurrect Ethnic Groups from Alcohol Abuse
6. NGOs and Various Groups Come Together To Address the Issues on AIDS
7. Anti-Obesity Groups Criticize Response of Medical Professionals
8. Hospitals Appeal to Citizen Groups to Rush Doctors, Paramedicals
9. Corporate Groups To Participate In Jharkhand Health Care Scheme
10. Incompatible Blood Groups Not A Hurdle For Kidney Transplant
11. Kids From Low-Income Groups Could Enhance Their Nutrition By Choosing Better After School Snacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... September 25, 2017 , ... Order Custom ... new website. No need to be concerned about garment selection, expensive graphic ... where all orders are printed and shipped within 5-10 days. And every ...
(Date:9/25/2017)... ... September 25, 2017 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that two of its leading biologics ... at two upcoming conferences. , At the BEBPA 10th Annual Bioassay Conference, to ...
(Date:9/25/2017)... ... 25, 2017 , ... NCPDP Foundation , a 501(c)(3) ... awarded a $40,000 grant to Johns Hopkins Medicine to address patient safety risk ... to electronically cancel a prescription already submitted to a pharmacy. Studies indicate that ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... and efficiency. The principle of First-Defect-Stop for laboratory weighing is designed ... have the chance to have negative consequences on downstream processes. , If a ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... science and technology-enabled services supporting clinical research, today announces that 30 of ... aspects of the drug development lifecycle at upcoming industry conferences and webinars. ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
Breaking Medicine Technology: